Found 25 matching trials
Optimization of Treatment in Patients With Severe Peripheral Ischemia (Fontaine Stage IIb)
PHASE4Evaluate the possibility of optimization of therapy with prostanoids (ilopr...
Location
Angiology, Hospital "G. Fucito"
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
PHASE3Single arm, open-label study to provide Defibrotide to patients diagnosed w...
Location
Children's Hospital of Alabama
Defibrotide for the Treatment of Severe COVID-19
PHASE2The goal of this study is to evaluate the safety and feasibility of defibro...
Location
Brigham and Women's Hospital
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients
PHASE3The purpose of this study is to (1) demonstrate the efficacy and safety (to...
Location
Multiple Locations
Defibrotide TMA Prophylaxis Pilot Trial
PHASE2Thrombotic microangiopathy (TMA) is a common complication in the stem cell ...
Location
Benioff Children's Hospital at UCSF Medical Center
Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma
PHASE2This phase II trial tests how well defibrotide works in preventing transpla...
Location
Multiple Locations
Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide
PHASE4Defibrotide is an anti-inflammatory and anti-coagulatory agent approved for...
Location
Department of Clinical Pharmacology, Medical University of Vienna
Defibrotide Compassionate Use for Patients With Life Threatening Veno-Occlusive Disease of the Liver
N/ASevere veno-occlusive disease (VOD) of the liver is a life threatening comp...
Status
No Longer Available
Location
Children's Healthcare of Atlanta
A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
PHASE2This is a prospective, open-label, single-arm study evaluating the safety a...
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome
PHASE2This study evaluates the safety of defibrotide in subjects with sickle cell...
Location
New York Medical College